Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. Genprex Inc. (GNPX) Message Board

Florida Approves Release of Engineered Mosquitoes

Message Board Public Reply | Private Reply | Keep | Replies (0)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 231
(Total Views: 384)
Posted On: 08/26/2020 3:08:17 AM
Avatar
Posted By: NetworkNewsWire
Florida Approves Release of Engineered Mosquitoes to Combat Viral Diseases

Some of the infectious ailments spread by mosquitoes such as yellow fever, Zika, Chikungunya, and dengue are growing concerns in the U.S. and globally. To successfully combat these diseases, you will have to deal with their vectors effectively. Recently, permission was granted to the piloting program in Florida to release genetically modified mosquitoes to the environment. The initiative is to help combat the spread of these infectious diseases.

The proponent of this project is Oxitec which aims at controlling and combating insect pests such as the medflies, mosquitoes, and diamondback moths. The project has been fully supported by the Florida Keys Mosquito Control District Board of Commissioners (“FKMCD”). The project is now going to be brought to reality after ten years of thorough planning.

Oxitec is planning to release male Aedes aegypti mosquitoes that are homozygous for self-limiting genes to the environment. After the Oxitec males mosquitoes are released in the environment, they will fertilize the female breeding mosquitoes. After fertilization, the gene will be adopted by both mosquitoes of which they will all turn out to be heterozygous. The female species will eventually die while the male will continue living. They will continue mating with other female progenies till the female species inherit 50% of their genes.

The remaining 50% of the female mosquitoes will maintain their population since they will not be affected by these male species. However, it would be best if you asked yourself this critical question; how many times will the male species be released to make this population control strategy essential in controlling these vectors?

Field trials have been performed by Oxitec in Brazil and Cayman Islands and have indicated that the method can be more productive. But you should ask yourself, will the strategy be useful in large areas like the Florida Keys or the whole Florida State? An additional question that you should also think about is that how many male specie mosquitoes will be required to run the project successfully? And how much will it cost for the program to be efficient?

However, the project will pave ways for other technologies that may make good impacts on these problems. One area that will have to be improved from the project is the removal of antibiotics from the procedure. It was noted that Oxitec mosquitoes were bred with the help of tetracycline to suppress the self-limiting gene. Tetracycline presence in the breeding of male mosquitoes could tamper with their fitness; hence more mosquitoes will be required for the process to be effective. If the project by Oxitec fails to succeed, it will be more cumbersome for other approaches of mosquito controls to be successful.

Another researcher has also developed the sterile insect technique (“SIT”), which is capable of producing 100% sterile male species that are also fit enough. The technology has demonstrated that it does not need antibiotics and can also be released in the form of eggs. The eggs can also be preserved for at least a year before being released. By combining these two technologies, controlling vectors can be successful, hence bringing a reduction in the diseases being spread by mosquitoes. The disease burden facing humanity is likely to go down if this project, together with the work being done by companies like Genprex Inc. (NASDAQ: GNPX) yields positive outcomes.

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer


(0)
(0)




Genprex Inc. (GNPX) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us